Biogened S.A. (WSE:BGD)
Poland flag Poland · Delayed Price · Currency is PLN
28.00
+1.00 (3.70%)
At close: Mar 31, 2025

Biogened Cash Flow Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
4.575.13.381.961.24
Upgrade
Depreciation & Amortization
4.133.522.942.884.49
Upgrade
Loss (Gain) From Sale of Assets
---0-0.62
Upgrade
Loss (Gain) From Sale of Investments
----0.49-
Upgrade
Other Operating Activities
2.372.161.70.590.86
Upgrade
Change in Accounts Receivable
0.21-0.424.07-2.13.05
Upgrade
Change in Inventory
-7.031.15-8.140.61-1.47
Upgrade
Change in Other Net Operating Assets
-0.253.362.06-0.311.16
Upgrade
Operating Cash Flow
414.876.013.148.71
Upgrade
Operating Cash Flow Growth
-73.13%147.34%91.42%-63.93%57.17%
Upgrade
Capital Expenditures
-5.49-7.15-9.36-1.57-1.83
Upgrade
Sale of Property, Plant & Equipment
----0.62
Upgrade
Investment in Securities
---0.49-
Upgrade
Investing Cash Flow
-5.49-7.15-9.36-1.08-1.21
Upgrade
Long-Term Debt Issued
7.72.345.565.845
Upgrade
Long-Term Debt Repaid
-5.07-6-5-5.82-10.97
Upgrade
Net Debt Issued (Repaid)
2.63-3.660.560.02-5.97
Upgrade
Common Dividends Paid
-1.23-0.98-0.74-0.49-0.49
Upgrade
Other Financing Activities
-1.350.982.010.830.31
Upgrade
Financing Cash Flow
0.05-3.661.840.36-6.15
Upgrade
Net Cash Flow
-1.444.06-1.512.421.35
Upgrade
Free Cash Flow
-1.497.72-3.351.576.88
Upgrade
Free Cash Flow Growth
----77.13%267.48%
Upgrade
Free Cash Flow Margin
-1.35%8.08%-4.21%2.41%14.23%
Upgrade
Free Cash Flow Per Share
-0.613.14-1.360.642.80
Upgrade
Cash Interest Paid
2.372.161.70.590.86
Upgrade
Levered Free Cash Flow
-5.696.42-3.067.8214.86
Upgrade
Unlevered Free Cash Flow
-4.217.77-28.215.4
Upgrade
Change in Net Working Capital
8.5-6.290.81-4.01-11.26
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.